Heather Marsden

Heather Marsden is a seasoned professional in the field of hematology and oncology, currently serving as a Senior Medical Science Liaison at SpringWorks Therapeutics since July 2021. In addition, Marsden holds an advisory role on the Board of Directors for the Neurofibromatosis Network since May 2022. Previous experience includes senior positions at Bristol Myers Squibb and Celgene, focusing on myeloma, lymphoma, and CAR T therapies. Marsden's extensive background includes roles at AstraZeneca and SMG Pharmaceuticals, alongside academic experience as an Associate Professor at ECPI University. Educational credentials include a Ph.D. in Hematology/Oncology & Molecular Biology from Whiddon College of Medicine at the University of South Alabama and a B.S. in Biology with a minor in Organic Chemistry from Liberty University.